These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32360642)

  • 1. Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Toxicol In Vitro; 2020 Sep; 67():104862. PubMed ID: 32360642
    [No Abstract]   [Full Text] [Related]  

  • 2. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
    [No Abstract]   [Full Text] [Related]  

  • 3. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine disruptors and human health.
    Latini G; Knipp G; Mantovani A; Marcovecchio ML; Chiarelli F; Söder O
    Mini Rev Med Chem; 2010 Aug; 10(9):846-55. PubMed ID: 20482499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Arch Toxicol; 2020 Jul; 94(7):2549-2557. PubMed ID: 32514609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why endocrine disrupting chemicals (EDCs) challenge traditional risk assessment and how to respond.
    Futran Fuhrman V; Tal A; Arnon S
    J Hazard Mater; 2015 Apr; 286():589-611. PubMed ID: 25646754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs.
    Street ME; Audouze K; Legler J; Sone H; Palanza P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent environmental endocrine-disrupting chemicals in ovarian follicular fluid and
    Björvang RD; Damdimopoulou P
    Ups J Med Sci; 2020 May; 125(2):85-94. PubMed ID: 32093529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A restatement of the natural science evidence base on the effects of endocrine disrupting chemicals on wildlife.
    Godfray HCJ; Stephens AEA; Jepson PD; Jobling S; Johnson AC; Matthiessen P; Sumpter JP; Tyler CR; McLean AR
    Proc Biol Sci; 2019 Feb; 286(1897):20182416. PubMed ID: 30963852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to modern, widespread environmental endocrine disrupting chemicals and their effect on the reproductive potential of women: an overview of current epidemiological evidence.
    Karwacka A; Zamkowska D; Radwan M; Jurewicz J
    Hum Fertil (Camb); 2019 Apr; 22(1):2-25. PubMed ID: 28758506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental epigenomics: Current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC's) on human health.
    Tapia-Orozco N; Santiago-Toledo G; Barrón V; Espinosa-García AM; García-García JA; García-Arrazola R
    Environ Toxicol Pharmacol; 2017 Apr; 51():94-99. PubMed ID: 28215500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational prediction models for assessing endocrine disrupting potential of chemicals.
    Sakkiah S; Guo W; Pan B; Kusko R; Tong W; Hong H
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018; 36(4):192-218. PubMed ID: 30633647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of Endocrine disrupting chemicals on myocardial fibrosis and related mechanism].
    Guo M; Xu J; Yu J
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Feb; 40(2):156-160. PubMed ID: 35255588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.